Third Harmonic Bio
THRD
THRD was delisted on the 30th of July, 2025.
105 hedge funds and large institutions have $210M invested in Third Harmonic Bio in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 22 closing their positions.
180% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 15
56% more capital invested
Capital invested by funds: $134M → $210M (+$75.7M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
27% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 22
6% more funds holding
Funds holding: 99 → 105 (+6)
0.16% less ownership
Funds ownership: 85.93% → 85.77% (-0.16%)
46% less call options, than puts
Call options by funds: $367K | Put options by funds: $685K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.69M |
| 2 |
D.E. Shaw & Co
New York
|
+$3.38M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$2.61M |
| 4 |
DAM
DLD Asset Management
New York
|
+$2.51M |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$2.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$8.23M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$2.94M |
| 3 |
NM
Newtyn Management
New York
|
-$2.2M |
| 4 |
Renaissance Technologies
New York
|
-$1.15M |
| 5 |
JP Morgan Chase
New York
|
-$842K |
THRD Hedge Fund Activity: Q2 2025 in Review
105 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q2 2025, worth a combined $210M — up 56% from $134M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new THRD positions and 22 closed out — a net gain of 6 holders — while 42 added to existing stakes and 15 trimmed.
The largest buyer was Schonfeld Strategic Advisors, adding an estimated $3.69M. The largest seller was BVF Inc, exiting entirely with an estimated $8.23M sold.
- 105 institutional investors held Third Harmonic Bio (THRD) as of Q2 2025, up from 99 in Q1 2025.
- Funds reported $210M of Third Harmonic Bio stock for Q2 2025, up 56% quarter-over-quarter.
- 28 funds opened new Third Harmonic Bio positions in Q2 2025 and 22 closed out, a net change of +6 holders.
- The largest Third Harmonic Bio buyer in Q2 2025 was Schonfeld Strategic Advisors, an estimated $3.69M added.
- The largest Third Harmonic Bio seller in Q2 2025 was BVF Inc, an estimated $8.23M sold.
Based on aggregated 13F filings for Q2 2025.